No evidence in US of HPV16/18 cancer precursor reduction

M Eli Pendleton¹, Mack T Ruffin 4th², Diane M Harper³

Affiliations

¹ Department of Family and Geriatric Medicine, University of Louisville School of Medicine, United States.
² Department of Family Medicine, University of Michigan Health System, United States.
³ Department of Family and Geriatric Medicine, University of Louisville School of Medicine, United States; Department of Obstetrics and Gynecology, University of Louisville School of Medicine, United States; Department of Epidemiology and Population Health, University of Louisville School of Public Health and Information Sciences, United States; Department of Health Promotion & Behavioral Health Sciences, University of Louisville School of Public Health and Information Sciences, United States. Electronic address: diane.m.harper@gmail.com.

PMID: 26232544
DOI: 10.1016/j.vaccine.2015.07.047

Comment

No evidence in US of HPV16/18 cancer precursor reduction

M Eli Pendleton et al. Vaccine. 2016.

. 2016 Jan 4;34(2):200.

doi: 10.1016/j.vaccine.2015.07.047. Epub 2015 Jul 29.

Authors

M Eli Pendleton¹, Mack T Ruffin 4th², Diane M Harper³

Affiliations

¹ Department of Family and Geriatric Medicine, University of Louisville School of Medicine, United States.
² Department of Family Medicine, University of Michigan Health System, United States.
³ Department of Family and Geriatric Medicine, University of Louisville School of Medicine, United States; Department of Obstetrics and Gynecology, University of Louisville School of Medicine, United States; Department of Epidemiology and Population Health, University of Louisville School of Public Health and Information Sciences, United States; Department of Health Promotion & Behavioral Health Sciences, University of Louisville School of Public Health and Information Sciences, United States. Electronic address: diane.m.harper@gmail.com.

PMID: 26232544
DOI: 10.1016/j.vaccine.2015.07.047

No abstract available

PubMed Disclaimer

Comment in

Response to Pendleton et al. regarding reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States.
Hariri S, Markowitz LE, Unger ER. Hariri S, et al. Vaccine. 2016 Jan 4;34(2):201. doi: 10.1016/j.vaccine.2015.10.138. Epub 2015 Dec 2. Vaccine. 2016. PMID: 26655631 No abstract available.

Comment on

Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States - 2008-2012.
Hariri S, Bennett NM, Niccolai LM, Schafer S, Park IU, Bloch KC, Unger ER, Whitney E, Julian P, Scahill MW, Abdullah N, Levine D, Johnson ML, Steinau M, Markowitz LE; HPV-IMPACT Working Group. Hariri S, et al. Vaccine. 2015 Mar 24;33(13):1608-13. doi: 10.1016/j.vaccine.2015.01.084. Epub 2015 Feb 11. Vaccine. 2015. PMID: 25681664 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

No evidence in US of HPV16/18 cancer precursor reduction

Affiliations

No evidence in US of HPV16/18 cancer precursor reduction

Authors

Affiliations

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical